Carbenoxolone
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171981This classification denotes a hydroxysteroid dehydrogenase inhibitor with the molecular formula C34H50O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MM6384NG73, chemically known as olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-, hydrogen succinate but generally known as carbenoxolone, which bears US NIH Compound Identifier 21913. Carbenoxolone comes in base, adrenochrome, and sodium forms. European Medicines Agency schedules Carbenoxolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06123MIG. The term CARBENOXOLONE is an International Non-Proprietary Name. World Health Organization schedules carbenoxolone in its Anatomical Therapeutic Chemical (ATC) Classification. CARBENOXOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CARBENOXOLONE remains the US FDA Preferred Term for this commodity. Carbenoxolone bears US NLM identifiers UMLS ID C0006979 and NCI Concept Code C63669. SMILES: O(C1C(C2C(C3C(C4(C(=CC3=O)C3C(CC4)(CCC(C3)(C)C(=O)O)C)C)(CC2)C)(CC1)C)(C)C)C(=O)CCC(=O)O.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.